Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
76,302
Employees76,302
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
76,302
Employees76,302

NVO Key Statistics

Market cap
262.29B
Market cap262.29B
Price-Earnings ratio
18.13
Price-Earnings ratio18.13
Dividend yield
1.97%
Dividend yield1.97%
Average volume
24.92M
Average volume24.92M
High today
$62.18
High today$62.18
Low today
$58.71
Low today$58.71
Open price
$60.21
Open price$60.21
Volume
30.42M
Volume30.42M
52 Week high
$93.80
52 Week high$93.80
52 Week low
$43.08
52 Week low$43.08

NVO News

Simply Wall St 4h
Hims And Hers Wegovy Talks Could Reshape Growth And Subscriber Economics

Hims & Hers Health (NYSE:HIMS) is in discussions with Novo Nordisk to add Wegovy injections to its telehealth platform. The talks also include potential access...

Hims And Hers Wegovy Talks Could Reshape Growth And Subscriber Economics
Simply Wall St 8h
Novo Nordisk Deepens Cell Therapy Push In Canada As Shares Screen Cheap

Novo Nordisk (NYSE:NVO) is expanding its partnership with Aspect Biosystems to advance cell-based diabetes treatments. The company is shifting some research an...

Novo Nordisk Deepens Cell Therapy Push In Canada As Shares Screen Cheap
The Motley Fool 15h
Is Oral Wegovy a Game Changer for Novo Nordisk?

The past couple of years have been challenging for the company. But this could be the beginning of a new chapter. Novo Nordisk (NVO 2.38%) was a pioneer in the...

Is Oral Wegovy a Game Changer for Novo Nordisk?

Analyst ratings

52%

of 33 ratings
Buy
51.5%
Hold
36.4%
Sell
12.1%

More NVO News

Sherwood News 17h
Pharma largely unfazed as Greenland tariffs roil markets

Drugmakers, which have spent the past six months reaching tariff deals with Trump, seem to expect some immunity from a new batch of tariffs on European countrie...

Pharma largely unfazed as Greenland tariffs roil markets
TipRanks 20h
Novo Nordisk: Buy Rating Maintained as Pipeline Strength and Franchise Durability Outweigh 2026 Patent and Competitive Headwinds

In a report released today, Michael Nedelcovych from TD Cowen maintained a Buy rating on Novo Nordisk, with a price target of $70.00. Claim 50% Off TipRanks Pre...

TipRanks 1d
‘Sales and Earnings to Shrink in 2026’ TD Cowen Says of Novo Nordisk Stock

TD Cowen analyst Michael Nedelcovych lowered his model estimates for Danish drugmaker Novo Nordisk (NVO), citing fierce competition in the incretin market, part...

Nasdaq 2d
Is Novo Nordisk's Oral Wegovy Driving Strong Early US Demand Already?

Shares of Novo Nordisk NVO rose 9.1% on Friday after the company reportedly recorded strong early prescription trends just one week following the early-January...

Is Novo Nordisk's Oral Wegovy Driving Strong Early US Demand Already?
Nasdaq 4d
Stock Market Today, Jan. 16: Space Stocks Take Off As Markets Slip

S&P 500 (SNPINDEX:^GSPC) slipped 0.06% to 6,940.01, today as political uncertainty won out over yesterday’s chip optimism. The Nasdaq Composite (NASDAQINDEX:^IX...

Stock Market Today, Jan. 16: Space Stocks Take Off As Markets Slip
Benzinga 5d
Why Is Wegovy Maker Novo Nordisk Stock Soaring? - Novo Nordisk - Benzinga

...

Why Is Wegovy Maker Novo Nordisk Stock Soaring? - Novo Nordisk - Benzinga
Barron's 5d
Novo Nordisk’s Wegovy Weight Loss Pill Has a Strong Launch—and Other Reasons the Stock Is Rising

Biotech and Pharma Novo Nordisk’s Wegovy Weight Loss Pill Has a Strong Launch—and Other Reasons the Stock Is Rising In this article NVO LLY The U.K.’s Medicines...

Novo Nordisk’s Wegovy Weight Loss Pill Has a Strong Launch—and Other Reasons the Stock Is Rising
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .